Radiotherapy quality assurance in the PROTECT trial – a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer

Camilla S. Byskov*, Hanna R. Mortensen, Marie Claude Biston, Sara Broggi, Rebecca Bütof, Richard Canters, Gilles Crehange, Gilles Defraene, Jerome Doyen, Mai L. Ehmsen, Silvia Fabiano, Francesco Fracchiola, Farid Goudjil, Karin Haustermans, Sarah E. Jensen, Maria F. Jensen, Marie Lecornu, Sebastian Makocki, Aurélia L. Mana, An Drea MartignanoArturs Meijers, Alfredo Mirandola, Diana A. Mitrea, Christina T. Muijs, Ditte S. Møller, Marianne Nordsmark, Ester Orlandi, Panagiotis Balermpas, Pieter Populaire, Daniele Scartoni, Jessica Serrand, Muham Mad Shamshad, Najla Slim, Valentina Vanoni, Anthony Vela, Marie Vidal, Gloria Vilches-Freixas, Damien Weber, Lone Hoffmann

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

Fingerprint

Dive into the research topics of 'Radiotherapy quality assurance in the PROTECT trial – a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology